StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Verastem's total debt was $25.06M at Sep 30, 2018. For fiscal 2017 it was $14.83M.

Annual total debt

PeriodPeriod endValueChange
FY2017Dec 31, 2017$14.83M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2018Sep 30, 2018$25.06M+973.4%
Q2 FY2018Jun 30, 2018$24.90M+986.1%
Q1 FY2018Mar 31, 2018$14.91M+563.1%
Q4 FY2017Dec 31, 2017$14.83M–
Q3 FY2017Sep 30, 2017$2.34M–
Q2 FY2017Jun 30, 2017$2.29M–
Q1 FY2017Mar 31, 2017$2.25M–

More Verastem figures

See a number that looks wrong?